Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

424.04 1.95 +0.46%
Market cap
$92.2B
P/E
18.8×
Fwd P/E
20.3×
Dividend yield
1.62%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. 10-Q filed Jul 15, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed · accepted 11:27 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Apr 22, 2026: 26 added · 7 removed · 39 modified; 14 with only figures updated; 2 moved without change

  1. Modified · (In Millions, Except Per Share Data or as Otherwise Stated Herein)

    Results of operations, cost of care trends, investment yields and other measures for the three and six months ended March 31June 30, 2026 are not necessarily indicative of the results and trends that may be expected for the full year ending December 31, 2026, or any other period.

71 more changes in this Item, word by word, in Powerpack.

Powerpack